stroke
Lundbeck scraps stroke drug
December 18, 2014Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke
Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …
Pradaxa ‘safe’ says Australian regulator
August 6, 2014Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke
Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …
ReNeuron relocates to Wales
July 22, 2013Research and Development, Sales and Marketing ReNeuron, Wales, stem cell, stroke
The Welsh government is to fork out a £7.8 million grant package to get English stem cell research company ReNeuron …
Xbox Kinect technology to help stroke victims
June 19, 2012Medical Communications Gamification, Roke, Southampton, Xbox, stroke
The University of Southampton and Roke Manor Research have pioneered the use of Microsoft’s Xbox technology to help stroke patients …
Petition launched to raise AF and stroke awareness
April 20, 2012Business Services, Medical Communications, Sales and Marketing AF, Boehringer Ingelheim, Pradaxa, Xarelto, stroke
Various health organisations have called on more people involved in the management of atrial fibrillation (AF) to help raise awareness …
Stroke crisis to hit UK unless government acts, warns report
December 5, 2011Sales and Marketing BMS, Pfizer, Pradaxa, UK, stroke
Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …
FDA recommends Xarelto for new approval
September 12, 2011Sales and Marketing Xarelto, atrial fibrillation, stroke
FDA advisors have recommended Bayer and Johnson & Johnson’s Xarelto be approved in the US for the prevention of stroke …
Stem cell trial for stroke is safe
September 1, 2011Research and Development ReNeuron, Stem cells, stroke
A pioneering stem cell treatment for patients who have suffered a stroke has been ruled safe, and can continue to …
UK dementia awareness campaign launched
March 11, 2011Medical Communications dementia, disease awareness, disease awareness campaigns, stroke
The Department of Health has launched a £1.2 million awareness campaign which aims to alert people to the early signs …
Merck suffers late-stage blow to vorapaxar
January 18, 2011Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar
An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …
First patient treated in groundbreaking stem cell trial
November 16, 2010Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke
The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …
Stroke awareness campaign planned
December 11, 2008Medical Communications stroke
A three-year campaign to raise awareness of stroke will begin in February, using a mixture of advertising, PR and direct …
World’s first stem cell trial for stroke likely to get green light
January 19, 2007Research and Development ReNeuron, stem cell, stroke
A cutting-edge stem cell clinical trial for chronic stroke patients looks set to go ahead later this year.Biotech company ReNeuron, …
AstraZeneca doubles trial size for stroke drug
December 13, 2005Research and Development AstraZeneca, stroke
Late stage clinical trials of AstraZeneca’s new stroke treatment have resumed after the company decided to double the number of …
